ASM-8

N/A

Report date: 2022/07/04 19:38:02

NME

Base Information

Drug NameASM-8

Drug Alias NameASM-8TPI-ASM-8

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense

Mechanisms of ActionC-C chemokine receptor type 3 antagonistsGranulocyte-macrophage colony-stimulating factor receptor antagonistsInterleukin 3 receptor antagonists +[4]

TargetsInterleukin-5 receptor subunit alphaInterleukin 3 receptorC-C chemokine receptor type 3 +[4]

Therapy Area/IndicationsAsthma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanadaUnited Kingdom

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesSyntara Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSyntara Ltd

Active IndicationsN/A

Inactive IndicationsAsthma

Other Information

ATC CodeN/A